xCures - About the company
xCures is a series B company based in Oakland (United States), founded in 2018. It operates as a Developer of an AI-assisted healthcare data platform. xCures has raised $76M in funding from Boehringer Ingelheim Venture Fund and Innovius Capital. The company has 228 active competitors, including 55 funded and 25 that have exited. Its top competitors include companies like Verily, IQVIA and Innovaccer.
Company Details
Developer of an AI-assisted healthcare data platform. It extracts and structures clinical information from medical records gathered across multiple sources. The AI-ready output is available through the xCures Platform UI, standard REST API integrations, and via flexible export and sync options.
- Website
- xcures.com
- Email ID
- *****@xcures.com
- Phone Number
- +1 **********
- Registered Address
- 1901 Harrison Street Suite 1100, Oakland, CA 94612, US
Key Metrics
Founded Year
2018
Location
Oakland, United States
Stage
Series B
Total Funding
$76M in 3 rounds
Latest Funding Round
Investors
Ranked
7th among 228 active competitors
Employee Count
73 as on Sep 30, 2026
Legal entities associated with xCures
xCures is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
xCures, Inc. CIN: 20211541741 , United States, Active | Jun 09, 2021 | - | - | - |
Sign up to download xCures' company profile
xCures's funding and investors
xCures has raised a total funding of $76M over 3 rounds. Its first funding round was on Jun 23, 2021. Its latest funding round was a Series B round on Jun 25, 2026 for $*****. 4 investors participated in its latest round. xCures has 13 institutional investors.
Here is the list of recent funding rounds of xCures:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 25, 2026 | 7913490 | Series B | 7504223 | 3643208 | 6486867 | 1726630 |
Dec 2023 | 2021010 | Series A | 3616500 | 9895467 | 4232808 | 1278932 |
Jun 23, 2021 | 6284758 | Series A | 9793969 | 3391011 |
View details of xCures's funding rounds and investors
xCures' founders and board of directors
Founder? Claim ProfilexCures' employee count trend
xCures has 73 employees as of Sep 26. Here is xCures's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
xCures's Competitors and alternates
Top competitors of xCures include Verily, IQVIA and Innovaccer. Here is the list of Top 10 competitors of xCures, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Verily 2015, Dallas (United States), Series D | A data platform and technology company purpose-built to power AI-enabled precision health | $2.8B | 82/100 | |
2nd | IQVIA 1982, Durham (United States), Public | Provider of clinical research and commercialization solutions for healthcare | $1.74M | 80/100 | |
3rd | Innovaccer 2014, San Francisco (United States), Series F | Developer of healthcare data platforms and artificial intelligence agent software | $675M | 78/100 | |
4th | Manifold AI 2016, Oakland (United States), Series B | Provider of an AI platform for life sciences research and development | $40M | 71/100 | |
5th | HealthVerity 2014, Philadelphia (United States), Series D | Cloud based healthcare and consumer data platform | $142M | 65/100 | |
6th | Skypoint 2019, Beaverton (United States), Series B | Developer of AI platform for healthcare analytics, agents, and workflow automation | $7.97M | - | 64/100 |
7th | xCures 2018, Oakland (United States), Series B | Developer of an AI-assisted healthcare data platform | $76M | 58/100 | |
8th | 1upHealth 2017, Boston (United States), Series C | Cloud based platform for practice and EHR management | $80.4M | 62/100 | |
9th | ESO 2004, Austin (United States), Series B | Provider of integrated software for emergency medical services | $50.4M | 61/100 | |
10th | CluePoints 2012, King Of Prussia (United States), Acquired | Provider of AI-based software for risk-based monitoring and data quality oversight for clinical trial studies | $6.55M | 60/100 |
Looking for more details on xCures's competitors? Click here to see the top ones
xCures's Investments and acquisitions
xCures has made no investments or acquisitions yet.
Reports related to xCures
Here is the latest report on xCures's sector:
News related to xCures
Media has covered xCures for a total of 6 events in the last 1 year, 3 of them have been about company updates and 1 about partnerships.
•
xCures Secures $46M Series B Funding Led by Innovius Capital for AI-Powered Clinical Data PlatformThe SaaS News•Jun 25, 2026•xCures, Spring Mountain Capital, iGrow, G KCC and 2 others
•
•
•
•
xCures Achieves HITRUST e1 Certification Demonstrating Commitment to Foundational CybersecurityxCures•May 13, 2025•xCures
•
•
Atropos Health and xCures Advance Artificial Intelligence (AI) to Improve Clinical Decision Making and Patient OutcomesBusiness Wire•Jan 14, 2025•Atropos Health, xCures
•
xCures Unveils Next-Generation AI-Powered Data Platform at HLTH ConferencePR Newswire•Oct 22, 2024•xCures
•
xCures Connects as a Qualified Health Information Network (QHIN) ParticipantPR Newswire•Oct 03, 2024•xCures
•
Clarified Precision Medicine, xCures Partner to Improve Clinical Decision Support PlatformsPrecision Oncology News•Jun 05, 2024•Clarified Precision Medicine, xCures
Are you a Founder ?
FAQs about xCures
Explore our recently published companies
- Hiero Partners - Manchester based, 2026 founded, Unfunded company
- Grateful Panda - 2026 founded, Unfunded company
- Smsrglobal - Unfunded company
- Enerdynesolutions - 2000 founded, Unfunded company
- Counterpart - 2026 founded, Unfunded company
- Earthwork - Unfunded company